EFEarnings Feed

Filing detail

6-KTicker CMNDCIK 0001892500

Clearmind Medicine Inc. 6-K

Accession 0001213900-25-112114

Filed Nov 17, 7:00 PM ETAccepted Nov 18, 4:16 PM ETSize 35.5 KB
View on sec.gov ↗Open company profile

Filed (ET)

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:16 PM ET

File size

35.5 KB

SEC accession

0001213900-25-112114

Filing details

Company
Clearmind Medicine Inc.
CIK
0001892500
Incorporated
Canada (Federal Level)
Entity type
other

Related parties

  • filerCIK 0001892500

Documents

Attached files
3 items

  • ea0266184-6k_clearmind.htm

    6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PrimaryOpen file ↗

  • ea026618401ex99-1_clearmind.htm

    EX-99.1

    PRESS RELEASE TITLED: "CLEARMIND MEDICINE ANNOUNCES POSITIVE TOP-LINE RESULTS FROM FIRST COHORT OF ITS FDA-APPROVED PHASE I/IIA CLINICAL TRIAL FOR ALCOHOL USE DISORDER"

    Open file ↗

  • ex99-1_001.jpg

    GRAPHIC

    GRAPHIC

    Open file ↗